Skip to main content
Equibles

Mark Plavsic

Board Member

Aura Biosciences, Inc. (AURA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Mark Plavsic

Mark Plavsic is recorded as Board Member at Aura Biosciences, Inc. (AURA). Fate Therapeutics Inc reported in an 8-K filed January 5, 2023 that Mark Plavsic was terminated as Chief Technical Officer, effective March 6, 2023. The proxy statement of Fate Therapeutics Inc reports total compensation of $3,266,951 for Mark Plavsic in fiscal 2022, including a base salary of $455,000. Disclosed compensation is on record for 2 fiscal years.

“the employment of Mark Plavsic, Ph.D., D.V.M., the Company's Chief Technical Officer, is expected to terminate effective as of March 6, 2023.”
Fate Therapeutics Inc Form 8-K, filed January 5, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Aura Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Fate Therapeutics Inc (FATE) $455,000 $3,266,951
2021 Fate Therapeutics Inc (FATE) $230,137 $8,379,027

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.